Stuart M. Gardos
Memorial Sloan Kettering Cancer Center · 45 works · 7,532 citations · h-index 14
Top works
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- AACR Project GENIE: Powering Precision Medicine through an International Consortium
- Cancer therapy shapes the fitness landscape of clonal hematopoiesis
- Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal
- OncoTree: A Cancer Classification System for Precision Oncology
- Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer
- Automated eligibility screening and monitoring for genotype-driven precision oncology trials
- Implications of Selection Bias Due to Delayed Study Entry in Clinical Genomic Studies
- Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- Characteristics and Outcome of AKT1 E17K-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic Registry
- An Empirical Analysis of Topic Modeling for Mining Cancer Clinical Notes
- Correlation Between Surrogate End Points and Overall Survival in a Multi-institutional Clinicogenomic Cohort of Patients With Non–Small Cell Lung or Colorectal Cancer
- Oncologic therapy shapes the fitness landscape of clonal hematopoiesis
- Linked Entity Attribute Pair (LEAP): A Harmonization Framework for Data Pooling
- Real-World Outcomes of an Automated Physician Support System for Genome-Driven Oncology
- A single-institution (MSKCC) analysis of incidence and clinical outcomes in patients with thromboembolic events and exocrine pancreas cancer.
- Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis
- An Empirical Analysis of Topic Modeling for Mining Cancer Clinical Notes
- Oncologic Therapy for Solid Tumors Alters the Risk of Clonal Hematopoiesis
- PRECISE: A clinical-grade automated molecular eligibility screening and just-in-time (JIT) physician decision support solution for molecularly-selected oncology trials.